Studies thus far have demonstrated that MMP-9 is substantially overexpressed in many brain diseases, which acts as not only a proteolytic enzyme involved in the disruption of the blood–brain barrier (BBB), but also an inflammatory mediator playing an important role in neuroinflammation [8,9,10]. Here, MMP9 is linked to brain disorder.